Jay Spiegel, Juan Alderuccio, Amer Beitinjaneh, Trent Wang, Noa Holtzman, Denise Pereira, Mark Goodman, Antonio Jimenez Jimenez, Cara Benjamin, Alvaro Alencar, Georgios Pongas, Izidore S. Lossos, Joseph Rosenblatt, Jonathan Schatz, Michele Stanchina, Asaad Trabolsi, Juan Carlos Ramos, Craig Moskowitz, Robby Friedman, Keerthi Paladugu, Michelle Menard, Damian Green, Lazaros Lekakis. "Mosunetuzumab and polatuzumab combined with axicabtagene ciloleucel induce high complete response rates at day+90 in Relapsed/Refractory large B-cell lymphoma." Blood, 2025. doi:10.1182/blood-2025-1009